Artivion | CRY - Current Assets


Artivion reported $338.81M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 338.81M 32.57M Sep/2026
AtriCure USD 363.39M 17.86M Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Boston Scientific USD 8.16B 192M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Integra LifeSciences USD 1.19B 1.54M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 430.79M 15.34M Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
ResMed USD 3.51B 815.82M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Tandem Diabetes Care USD 820.72M 16.08M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Terumo JPY 877.74B 28.86B Sep/2026
Trinity Biotech USD 31.36M 4.54M Mar/2026